JOSEPH JANKOVIC to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.722
-
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-a-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol. 2018 10 01; 75(10):1206-1214.
Score: 0.452
-
Parkinsonism and dystonia associated with adalimumab. Mov Disord. 2011 Jul; 26(8):1556-8.
Score: 0.270